FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation

The curative potential of allogeneic hematopoietic cell transplantation (allo-HCT) for acute myeloid leukemia (AML) relies on the graft-versus-leukemia (GVL)-effect. Relapse after allo-HCT occurs in a considerable proportion of patients, and has a dismal prognosis with very limited curative potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Biavasco, Francesca, Zeiser, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Progress in Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392688/
https://www.ncbi.nlm.nih.gov/pubmed/35460465
http://dx.doi.org/10.1007/s12185-022-03352-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392688/
https://www.ncbi.nlm.nih.gov/pubmed/35460465
http://dx.doi.org/10.1007/s12185-022-03352-6

Ejemplares similares